Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Regulatory Filings 2024

May 15, 2024

33003_rns_2024-05-15_cf9bde01-d119-48b7-81fd-6f8d23c3e013.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm CORRESP

May 15, 2024

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attention: Jimmy McNamara

Re: Solid Biosciences Inc.

Registration Statement on Form S-3

Filed March 13, 2024

File No. 333-277871

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-277871), so that it may become effective at 9:30 a.m., Eastern time, on May 17, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

Very truly yours,

By:
Alexander Cumbo
Chief Executive Officer